12th Oct 2010 11:00
SPH.L Sinclair Pharma plc ("Sinclair" or the "Company") Grant of share awards
Sinclair Pharma plc ("Sinclair" or "the Company": SPH:L), the international specialty pharma company, announces that on 4 October 2010 shares were issued in relation to performance share awards that vested under the 2003 Executive Share Incentive Plan to Alan Olby, CFO, and Stephen Redman, Legal Director and Company Secretary. The details of the awards are set out below:
Name Exercise Shares Total options Price allotted and share awards held Alan Olby 1p 52,127 171,748 Stephen Redman 1p 40,017 190,000
For further information please contact:
Sinclair Pharma plc Tel: +44 (0)1483 410 600Chris Spooner, CEOAlan Olby, CFOSinger Capital Markets Ltd Tel: +44 (0)20 3205 7500Shaun DobsonClaes Sp¥ng
Biddicks, Financial Public Relations Tel: +44 (0)20 7448 1000
Shane DolanNotes to Editors:
About Sinclair Pharma Plc www.sinclairpharma.com
Sinclair Pharma plc is an international specialty pharmaceutical company providing solutions to treat wounds, dermatological and oral diseases through advanced surface technology and innovative delivery systems. It has a growing sales and marketing operation that is present in France, Italy, Germany and Spain, and an extensive marketing partner network across selected developed and emerging markets.
"Safe Harbor" Statement under the US Private Securities Litigation Reform Act of 1995: Some or all of the statements in this document that relate to future plans, expectations, events, performances and the like are forward-looking statements, as defined in the US Private Securities Litigation Reform Act of 1995. Actual results of events could differ materially from those described in the forward-looking statements due to a variety of factors.
vendorRelated Shares:
Sinclair Pharma